161 related articles for article (PubMed ID: 33054395)
1. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
[TBL] [Abstract][Full Text] [Related]
2. Drebrin regulates angiotensin II-induced aortic remodelling.
Zhang L; Wu JH; Huang TQ; Nepliouev I; Brian L; Zhang Z; Wertman V; Rudemiller NP; McMahon TJ; Shenoy SK; Miller FJ; Crowley SD; Freedman NJ; Stiber JA
Cardiovasc Res; 2018 Nov; 114(13):1806-1815. PubMed ID: 29931051
[TBL] [Abstract][Full Text] [Related]
3. Cellular Repressor of E1A-Stimulated Genes Is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II.
Li Y; Liu Y; Tian X; Zhang Y; Song H; Liu M; Zhang X; Liu H; Zhang J; Zhang Q; Liu D; Peng C; Yan C; Han Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):485-494. PubMed ID: 28062494
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection.
Fan LM; Douglas G; Bendall JK; McNeill E; Crabtree MJ; Hale AB; Mai A; Li JM; McAteer MA; Schneider JE; Choudhury RP; Channon KM
Circulation; 2014 Jun; 129(25):2661-72. PubMed ID: 24807872
[TBL] [Abstract][Full Text] [Related]
6. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
Sparks MA; Parsons KK; Stegbauer J; Gurley SB; Vivekanandan-Giri A; Fortner CN; Snouwaert J; Raasch EW; Griffiths RC; Haystead TA; Le TH; Pennathur S; Koller B; Coffman TM
Hypertension; 2011 Mar; 57(3):577-85. PubMed ID: 21242463
[TBL] [Abstract][Full Text] [Related]
8. Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling.
Emmerson A; Trevelin SC; Mongue-Din H; Becker PD; Ortiz C; Smyth LA; Peng Q; Elgueta R; Sawyer G; Ivetic A; Lechler RI; Lombardi G; Shah AM
J Clin Invest; 2018 Jul; 128(7):3088-3101. PubMed ID: 29688896
[TBL] [Abstract][Full Text] [Related]
9. FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells via Activating the AMPK-SIRT1 Signal Pathway.
Zhou B; Qiu Y; Wu N; Chen AD; Zhou H; Chen Q; Kang YM; Li YH; Zhu GQ
Oxid Med Cell Longev; 2020; 2020():6384803. PubMed ID: 32509148
[TBL] [Abstract][Full Text] [Related]
10. Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell NAPDH Oxidase 2 on Blood Pressure.
Sag CM; Schnelle M; Zhang J; Murdoch CE; Kossmann S; Protti A; Santos CXC; Sawyer G; Zhang X; Mongue-Din H; Richards DA; Brewer AC; Prysyazhna O; Maier LS; Wenzel P; Eaton PJ; Shah AM
Circulation; 2017 May; 135(22):2163-2177. PubMed ID: 28298457
[TBL] [Abstract][Full Text] [Related]
11. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
12. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
13. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
[TBL] [Abstract][Full Text] [Related]
15. Krüppel-Like Factor 15/Interleukin 11 Axis-Mediated Adventitial Remodeling Depends on Extracellular Signal-Regulated Kinases 1 and 2 Activation in Angiotensin II-Induced Hypertension.
Guo YT; Lu YY; Lu X; He S; Li SJ; Shao S; Zhou HD; Wang RQ; Li XD; Gao PJ
J Am Heart Assoc; 2021 Aug; 10(16):e020554. PubMed ID: 34350769
[TBL] [Abstract][Full Text] [Related]
16. Icariin ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting Nox2-containing NADPH oxidase activation.
Dong H; Ming S; Fang J; Li Y; Liu L
Hum Cell; 2019 Jan; 32(1):22-30. PubMed ID: 30386989
[TBL] [Abstract][Full Text] [Related]
17. BCL6 Attenuates Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells in Hypertension.
Chen D; Zang YH; Qiu Y; Zhang F; Chen AD; Wang JJ; Chen Q; Li YH; Kang YM; Zhu GQ
Oxid Med Cell Longev; 2019; 2019():5018410. PubMed ID: 30805081
[TBL] [Abstract][Full Text] [Related]
18. Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction.
Murdoch CE; Alom-Ruiz SP; Wang M; Zhang M; Walker S; Yu B; Brewer A; Shah AM
Basic Res Cardiol; 2011 Jun; 106(4):527-38. PubMed ID: 21528437
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
